SCHEMBL6537705

SCHEMBL6537705

CN1CCN(c2c(CO)cnc3c(NC(=O)c4c(Cl)cccc4Cl)cccc23)C1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
HTT P42858 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
LCK P06239 1/20 0.36
MAPK14 Q16539 1/20 0.36
JAK2 O60674 4/20 0.36
JAK1 P23458 2/20 0.36
TYK2 P29597 2/20 0.36
NPC1 O15118 2/20 0.35
KDR P35968 1/20 0.34
POLB P06746 1/20 0.34
SLC16A3 O15427 1/20 0.34
MAPT P10636 2/20 0.34
PABPC1 P11940 1/20 0.34
EIF4H Q15056 1/20 0.34
TP53 P04637 1/20 0.34
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537657 0.91 PTGES (0.37) MEN1KMT2AHTTSMN1; SMN2CRHBP
SCHEMBL6537474 0.90 LCK (0.36) MEN1KMT2AHTTSMN1; SMN2CRHBP
SCHEMBL6537499 0.90 KMT2A (0.35) MEN1KMT2AHTTSMN1; SMN2CRHBP
SCHEMBL1230631 0.89 MAPT (0.39) MEN1KMT2AHTTSMN1; SMN2CRHBP
SCHEMBL6538181 0.87 MEN1 (0.34) MEN1KMT2AHTTSMN1; SMN2CRHBP
SCHEMBL6537953 0.81 PTGES (0.37) MEN1KMT2AHTTSMN1; SMN2CRHBP
SCHEMBL6538217 0.81 PTGES (0.37) MEN1KMT2ALCKMAPK14JAK2
SCHEMBL8471061 0.81 TP53 (0.42) MEN1KMT2AHTTSMN1; SMN2CRHBP
SCHEMBL6538350 0.81 TYK2 (0.43) MEN1KMT2AHTTSMN1; SMN2CRHBP
SCHEMBL6537582 0.80 MEN1 (0.40) MEN1KMT2AHTTSMN1; SMN2CRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 WO disclosed